FDA Inspection 1082606 — University Of Maryland Medical Center Midtown Campus
The FDA completed an inspection of University Of Maryland Medical Center Midtown Campus on Mar 1, 2019 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Baltimore, MD (United States)